Seminars in Oncology
Volume 33, Supplement 5 , Pages 36-43, April 2006

The Role of Alemtuzumab in Nonmyeloablative Hematopoietic Transplantation

  • Sergio Giralt

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Sergio Giralt, MD, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 423, Houston, TX 77030, USA

University of Texas M. D. Anderson Cancer Center, Houston, TX.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00060-1

doi:10.1053/j.seminoncol.2006.01.028

Seminars in Oncology
Volume 33, Supplement 5 , Pages 36-43, April 2006

Article Tools

* Image Usage & Resolution